L M Lesmeister
1PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (1)
Sort by Publication Date:
|Jan 17, 2022
Infliximab is an appropriate second-line therapy in infants with steroid refractory pyoderma gangrenosum.L M Lesmeister, J Peitz, J C von Kleist-Retzow
Pageof 1
